Anne Walton, MD
Family Medicine · Newark, DENPI 1902834997
Payments from drug & device makers
Across 63 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$182
- Novo Nordisk$131
- Lilly USA, LLC$89
- Amgen$68
- Ironshore Pharmaceuticals Inc.$66
- Takeda Pharmaceuticals U.S.A., Inc.$66
- plus $457 from 19 others
What the payments were for
- Food & beverage$1,02297%
- Education$373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $182 |
| Novo Nordisk | 7 | $131 |
| Lilly USA, LLC | 6 | $89 |
| Amgen | 4 | $68 |
| Ironshore Pharmaceuticals Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $66 |
| Merck | 3 | $54 |
| Bayer | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Astellas Pharma US Inc | 2 | $33 |
| Exact Sciences | 2 | $30 |
| Gilead | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| VBI Vaccine (delaware) Inc. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| GSK | 1 | $13 |
| Seqirus USA Inc | 1 | $12 |
How this compares
$1,059 in reported general payments places this provider in the 70th percentile of 352 family medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 12 | $744 |
| Atorvastatin Calcium | 27 | $430 |
| Alprazolam | 40 | $417 |
| Omeprazole | 29 | $385 |
| Rosuvastatin Calcium | 15 | $368 |
| Amlodipine Besylate | 42 | $344 |
| Losartan Potassium | 38 | $286 |
| Metformin Hcl | 20 | $257 |
| Famotidine | 12 | $154 |
| Levothyroxine Sodium | 13 | $141 |
| Lisinopril | 17 | $127 |
| Hydrochlorothiazide | 18 | $100 |
| Alendronate Sodium | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Newark
- Michelle PapaNewark$23K
- Ian MyersNewark$17K
- Robert WinterNewark$12K
- Judy LimNewark$12K
- Huy leNewark$10K
- Arlen StoneNewark$10K
- Imelyn LaheyNewark$8K
- Angela Davis BrownNewark$8K
- Robert CallahanNewark$7K
- George NameyNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.